Product Description
The Global Equity GIC offers the growth potential of
a global diversified equity portfolio (the “Reference Portfolio”)
while ensuring peace of mind due to capital protection at
maturity.
Note
On November 16, 2020, Pfizer Inc. (NYSE: PFE) (“Pfizer”) completed the transaction to spin-off its Upjohn division and combine it with Mylan N.V. (Nasdaq: MYL) to form Viatris Inc. (Nasdaq: VTRS) (“Viatris”), triggering a Potential Adjustment Event as per the terms and conditions of the market-linked GICs in respect of the common shares of Pfizer, a Reference Share in the Reference Portfolio of the market-linked GICs. As stockholders received common shares of Viatris, they were sold and reinvested in common shares of Pfizer. As a result, the Initial Value of the common shares of Pfizer was adjusted as of the closing of the markets on November 16, 2020.